Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Intern Med J ; 50(1): 92-99, 2020 01.
Article in English | MEDLINE | ID: mdl-30989773

ABSTRACT

BACKGROUND: Junior doctors experience high rates of psychological distress and burnout. System-level interventions are one strategy to reduce psychological distress in junior doctors. Unfortunately, few of these interventions have been evaluated. AIM: To evaluate the acceptability and effectiveness of a resilience and well-being programme designed for junior doctors. METHODS: A prospective cohort study of 24 medical interns at a teaching hospital in regional Queensland with a control group of 29 medical interns at a second teaching hospital in regional Queensland. Survey instruments to assess psychological distress, the ProQOL and K10, were completed at baseline, at the completion of the well-being programme, and 3 months after the completion of the well-being programme at both sites. RESULTS: The intervention site had an older cohort and fewer participants had a regular general practitioner compared to the control site. Both groups had moderate levels of psychological distress. Insufficient numbers of participants completing the instruments at the two sites meant that it was not possible to demonstrate differences between the groups; however, the trends were promising. Qualitative evaluation data supported these trends, indicating that the Resilience on the Run programme was positively received and provided useful skills to junior doctors. CONCLUSION: Well-being programmes benefit medical interns; introducing new knowledge and skills for effectively identifying and managing personal and workplace stressors that can contribute to psychological distress.


Subject(s)
Burnout, Professional/prevention & control , Internship and Residency/organization & administration , Medical Staff, Hospital/psychology , Occupational Health , Resilience, Psychological , Adult , Female , Hospitals, Teaching , Humans , Job Satisfaction , Male , Middle Aged , Program Evaluation , Prospective Studies , Queensland , Surveys and Questionnaires , Young Adult
5.
Aust Health Rev ; 37(4): 409-11, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23827256

ABSTRACT

Unaccredited registrar positions are a significant source of inefficiency in postgraduate medical training. Their educational value is debated due to a lack formal supervision, appraisal or assessment requirements. In the context of increasing numbers of trainees and escalating demand for public hospital services, the extent to which unaccredited registrar positions can be converted to accredited training posts warrants urgent examination. The major obstacle is meeting college standards, particularly with respect to caseload and supervision requirements. Notwithstanding the barriers to reform, this article describes how a coordinated process to accredit these posts would increase training capacity and enhance vertical integration in postgraduate medical education.


Subject(s)
Accreditation , Hospitals, Public , Medical Staff, Hospital , Australia , Education, Medical, Graduate/organization & administration , Humans
6.
7.
Aust Fam Physician ; 33(11): 910-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15584331

ABSTRACT

BACKGROUND: Since the last series of guidelines on the management of osteoporosis from Osteoporosis Australia was published in Australian Family Physician (October 2002), there have been further advances in our understanding of the treatment involved in both the prevention of bone loss and the management of established osteoporosis. OBJECTIVE: This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling.


Subject(s)
Family Practice/methods , Family Practice/standards , Osteoporosis, Postmenopausal/diagnosis , Osteoporosis, Postmenopausal/therapy , Absorptiometry, Photon , Aged , Antihypertensive Agents/therapeutic use , Benzothiadiazines , Biomarkers/blood , Bone Diseases, Metabolic/complications , Bone Diseases, Metabolic/diagnosis , Bone Diseases, Metabolic/therapy , Calcium/therapeutic use , Diphosphonates/therapeutic use , Diuretics , Drug Therapy, Combination , Estrogen Replacement Therapy/methods , Female , Fractures, Bone/etiology , Fractures, Bone/prevention & control , Humans , Middle Aged , Organometallic Compounds/therapeutic use , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/complications , Parathyroid Hormone/therapeutic use , Risk Factors , Selective Estrogen Receptor Modulators/therapeutic use , Sodium Chloride Symporter Inhibitors/therapeutic use , Thiophenes/therapeutic use , Vitamin D/therapeutic use
8.
Aust Fam Physician ; 31(10): 921-8, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12404830

ABSTRACT

BACKGROUND: Osteoporosis Australia has been committed to the education of general practitioners and the community with a series of updated guidelines on the management of osteoporosis. Since the last series was published in Australian Family Physician (August 2000), there have been further advances in our understanding of the treatments involved in both prevention of bone loss and the management of established osteoporosis. OBJECTIVE: This article represents updated guidelines for the treatment of postmenopausal osteoporosis to assist GPs identify those women at risk and to review current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone replacement therapy has mixed risks and benefits that requires individual patient counselling.


Subject(s)
Osteoporosis, Postmenopausal/therapy , Australia , Critical Pathways , Family Practice/methods , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/diagnosis , Referral and Consultation , Risk Factors , Risk Reduction Behavior
SELECTION OF CITATIONS
SEARCH DETAIL
...